◀ Back to FOS
FOS — ICAM1
Text-mined interactions from Literome
Lawson et al., J Immunol 1999
:
ICAM-1 cross linking
caused activation of Erk-1 and the
AP-1 transcription factor complex, without any increase in NF-kappaB activity, in contrast to TNF stimulation
Toyoshima et al., Biochem Biophys Res Commun 1999
(Carcinoma, Squamous Cell...) :
These findings indicate that NO up-regulates ICAM-1 expression on cancer cells by a regulatory mechanism involving PKC and suggest that NF-kappaB, but not
AP-1 , might be
involved in induction of
ICAM-1 by NO in cancer cells
Wang et al., Arterioscler Thromb Vasc Biol 1999
:
Adenovirus mediated overexpression of c-Jun and
c-Fos induces
intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells
Liao et al., Endothelium : journal of endothelial cell research 2000
:
We have demonstrated that PDTC not only induced AP-1 binding and ICAM-1 expression by itself, but it also augmented
AP-1 activation and
ICAM-1 induction in low-dose IL-1alpha treated cells
Chang et al., J Surg Res 2001
(Disease Models, Animal...) :
Therapeutic effect of dimethyl sulfoxide on
ICAM-1 gene expression and
activation of NF-kappaB and
AP-1 in septic rats ... We investigated the therapeutic effect of DMSO on
intercellular adhesion molecule 1 ( ICAM-1 ) gene expression and
activation of nuclear factor-kappaB (NF-kappaB) and
activating protein-1 (AP-1) in a rat model of peritonitis sepsis ... The levels of
ICAM-1 mRNA expression and
activation of NF-kappaB and
AP-1 in livers were determined at 3 and 6 h post-CI ... At 3 h post-CI surgery ( early sepsis ), DMSO treatment at 30 and 60 min post-CI surgery significantly inhibited sepsis induced
ICAM-1 mRNA expression and
activation of NF-kappaB and
AP-1 ... DMSO has no effect on
ICAM-1 gene expression and
activation of NF-kappaB and
AP-1 when administered at 90 min post-CI surgery
Schuringa et al., Cytokine 2001
:
Overexpression of c-Jun and
c-Fos strongly
enhanced STAT3-driven IRE transactivation as well as transactivation of the human
intercellular adhesion molecule (ICAM)-1 promoter
Wang et al., Arterioscler Thromb Vasc Biol 2001
:
In the present study, a regulated adenovirus expressing a dominant negative mutant of c-Jun ( TAM-67 ) was used to examine the
role of
AP-1 in the LDL induced
ICAM-1 activation
Chen et al., Mol Pharmacol 2004
:
TNF-alpha induced ICAM-1 promoter activity was attenuated using an activator protein-1 (AP-1) site deletion mutant, indicating the
involvement of
AP-1 in
ICAM-1 expression ... The inhibitory effects of apigenin and luteolin on
ICAM-1 expression are
mediated by the sequential attenuation of the three MAPKs activities, the c-fos and c-jun mRNA expressions, and the
AP-1 transcriptional activity
Franscini et al., Circulation 2004
(Vasculitis) :
Our study revealed a novel antiinflammatory mechanism of APC dependent gene regulation in HCAECs since
c-Fos dependent
induction of MCP-1 and
ICAM-1 was suppressed
Böhm et al., Exp Dermatol 2004
:
Functional studies have shown that alpha-MSH exerts anti-inflammatory actions in human fibroblastic skin cells by suppressing interleukin-1 (IL-1) induced IL-8 production,
activation of the transcription factor
activator protein-1 (AP-1) and induction of
intercellular adhesion molecule-1 by interferon-alpha
Yang et al., J Cell Physiol 2010
(Arthritis, Rheumatoid) :
IL-1beta induced
ICAM-1 expression, extracellular signal regulated kinase ( ERK ) and c-Jun-N-terminal kinase (JNK) phosphorylation, AP-1 activation, and nuclear factor-kappaB (NF-kappaB) p65 translocation were
attenuated by the inhibitors of MEK1/2 ( U0126 ), JNK ( SP600125 ),
AP-1 ( tanshinone IIA ), and NF-kappaB ( helenalin ) or transfection with respective short hairpin RNA plasmids ... These results suggest that in human RASFs, activation of ERK, JNK,
AP-1 , and NF-kappaB are
essential for IL-1beta induced
ICAM-1 expression and leukocyte adhesion
Yang et al., J Biol Chem 2010
(Mouth Neoplasms) :
PGE ( 2 ) -induced expression of
ICAM-1 and migration activity were
inhibited by a specific inhibitor, siRNA, and mutants of PKCd, c-Src, and
AP-1
Zhang et al., Zhonghua Jie He He Hu Xi Za Zhi 2010
(Ventilator-Induced Lung Injury) :
To study the expression of intercellular cell adhesion molecule-1 (
ICAM-1 ), Interleukin-10 (IL-10) and the
activation of transcription factor
activator protein-1 (AP-1) in a rabbit model of ventilator induced lung injury ( VILI ) and therefore to explore their possible role in VILI
Fong et al., J Cell Physiol 2012
(Bone Neoplasms...) :
In addition,
activator protein-1 (AP-1) inhibitors
suppressed the cell migration and
ICAM-1 expression enhanced by CCN6
Muñoz et al., J Immunol 1996
:
Taken together, these results indicate that the antioxidant PDTC induces transcriptional activation of
ICAM-1 and that this induction is
mediated at least in part by the transcription factor
AP-1
Koyama et al., J Immunol 1996
:
Cross linking of
intercellular adhesion molecule 1 ( CD54 )
induces AP-1 activation and IL-1beta transcription ... In this study, we provide the first evidence that
ICAM-1 engagement
induces activation of the transcription factor
AP-1 and transcription of the IL-1beta gene using a specific Ab to cross-link ICAM-1 on a rheumatoid synovial cell line ( E11 cells )
Kupatt et al., J Mol Cell Cardiol 1997
:
Because upregulation of
AP-1 through hypoxia alone did not
affect ICAM-1 expression, we conclude that redox-sensitive NFkappaB activation triggers ICAM-1 upregulation
Ishizuka et al., Clin Exp Immunol 1998
:
These findings suggest that
ICAM-1 or ELAM-1 expression of HUVEC stimulated via TXA2 receptors is
augmented by induction of NF-kappaB and
AP-1 binding activity through the PKC system, and that VCAM-1 expression is augmented by induction of NF-kappaB binding activity